Results for tag: "Neorecormon"

Neorecormon is a brand of hematological drugs used to treat anemia caused by chronic kidney disease. It is a recombinant human erythropoietin (rHuEPO) that stimulates the production of red blood cells in the body. Neorecormon is administered by subcutaneous injection and is available in a variety of formulations, including single-use vials, pre-filled syringes, and auto-injectors. The drug is also used to treat anemia caused by chemotherapy and other conditions. Neorecormon is a widely used drug in the hematological market, with a strong presence in Europe, the United States, and other countries. It is approved for use in adults and children, and is available in a variety of doses and formulations. Some companies in the Neorecormon market include Roche, Amgen, and Johnson & Johnson. Show Less Read more